Skip to main content
LFVN
NASDAQ Life Sciences

U.S. Patent Granted to LifeVantage for Healthy Glow Essentials Stack, Bolstering IP

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
7
Price
$5.25
Mkt Cap
$65.688M
52W Low
$3.9
52W High
$15
Market data snapshot near publication time

summarizeSummary

LifeVantage Corporation has been granted a U.S. Patent (No. 12,589,067 B2) for its Healthy Glow Essentials Stack, which includes Protandim Nrf2 Synergizer and TrueScience Liquid Collagen. This patent, issued March 31, 2026, protects the nutritional supplement composition and methods for activating cellular signaling genes, validating over three years of rigorous research and development. For a small-cap health and wellness company, securing intellectual property for a core product stack is a significant positive development, strengthening its competitive position and scientific credibility, especially following recent reports of revenue decline. This patent provides a defensive moat and could support future product claims and marketing efforts.

At the time of this announcement, LFVN was trading at $5.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $65.7M. The 52-week trading range was $3.90 to $15.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


show_chartPrice Chart

Share this article

Copied!

feed LFVN - Latest Insights

LFVN
Apr 21, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
LFVN
Apr 16, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
LFVN
Apr 02, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
LFVN
Mar 02, 2026, 6:44 PM EST
Filing Type: 4
Importance Score:
7
LFVN
Feb 04, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
9
LFVN
Feb 04, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
9